National and Kapodistrian University of Athens
Ο ρόλος της περιγεννητικής ιαιμίας της μητέρας στη μετάδοση του ιού της ηπατίτιδας Β στο νεογνό και η πρόβλεψη αυτής μέσω της ηπατικής βιοχημείας
Abstract
dc:descriptionIntroduction: The levels of maternal viremia (HBV–DNA) during the third trimester of pregnancy are the most important risk factor for perinatal transmission of hepatitis B virus (HBV) infection and for failure of the immunoprophylaxis applied. High levels of viremia are mainly observed in women with HΒeAg (+) chronic HBV infection. However, high-level viremia also occurs in a small percentage of women with HΒeAg (-) chronic HBV infection, while the cost of the specific examination remains quite high. Objective: The study was conducted in two phases. In the first phase, the aim was to evaluate commonly used laboratory parameters in pregnant women with HBeAg (-) chronic HBV infection and how these correlate with the presence or absence of viremia. In the second phase, the objective was to evaluate the perinatal viremia of HΒeAg (+) and HΒeAg (-) pregnant women and its contribution to the vertical transmission of the infection to their infants that have undergone complete immunoprophylaxis. Material – Method: A total of 219 pregnant women with chronic HBV infection were monitored and underwent hematological, biochemical, serological and virological testing between the 28th and 32nd week of pregnancy. In the first phase, the evaluation of liver enzymes for the prediction of viremia was performed on a population of asymptomatic pregnant women with HΒsAg(+)/HΒeAg(-) HBV infection. Out of the 101 women, who were eventually evaluated, 66 were HBV DNA positive and 35 HBV DNA negative. Out of the 66 women with detectable viremia, 21 had HBV DNA levels>2.000 IU/ml and 12 had HBV DNA levels>10.000 IU/ml. During the second phase, the investigation of perinatal viremia’s role in the vertical transmission of the hepatitis B virus was performed on a population of 52 [HΒsAg (+)/ HΒeAg (+) and HΒsAg (+)/HΒeAg (-)] pregnant women with HBV infection, as well as on their children respectively after approximately a year of monitoring. In this sample, 5 women were found positive for the presence of e antigen (HΒeAg), while the remaining 47 were HΒsAg (+)/HΒeAg (-). Their infants were administered the appropriate immunoprophylaxis scheme immediately after birth. Compliance to their subsequent vaccination coverage was also monitored.Results: In the first phase of the study, women with viremia exhibited significantly higher levels of ALT (25.43 IU/L vs. 15.50 IU/L, p=0.016) and γGT (17.47 IU/L vs. 10.22 IU/L, p=0.001) and a significantly lower number of white blood cells (10.527 vs. 13.793, p=0.008) and neutrophils (7.776 vs. 11.088, p=0.001) in relation to those with undetectable HBV-DNA (<8 IU/ml). The ideal limits that could distinguish women with the highest probability of viremia presence were 7 IU/L for γGT (sensitivity = 81.6%, specificity = 69.6%, AUC = 75.3%) and 12 IU/L for ALT (sensitivity = 74.1%, specificity = 56.2%, AUC = 65.4%). The positive predictive value for the presence of HBV DNA in women with both parameters above the new proposed limits was 88.8%, whereas the respective negative predictive value was 75%. During the second phase, 92.3% (48/52) of our final sample showed detectable HBV-DNA titles in the third trimester of pregnancy. Twenty five percent (25%; 13/52) of these women had HBV-DNA presence above 10000 IU/ML. Immunoprophylaxis failure was observed in 5.8% (3/52). The children that were found positive were born to mothers with high viremia (HBV-DNA>10000 IU/ML) and had HbeAg (+) presence during the perinatal period. The percentage of vertical transmission in women, who had HΒsAg (+)/ HΒeAg (+) serological profile was 60% (3/5), whereas in those with HΒsAg (+)/HΒeAg(-) profile, it was 0% (0/47). Conclusions: The presence of HBV-DNA in women in the third trimester of pregnancy correlates strongly with ALT and serum γGT levels. Women with γGT>7 IU/L and ALT>12 IU/L show the maximum probability of having detectable HBV-DNA. Mothers who showed high viremia (HBV-DNA>10000 IU/ML) and had HΒeAg (+) during the perinatal period, contributed to the vertical transmission of the virus to their children.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Derdemezi, Angeliki-Athina
- Δερδεμέζη, Αγγελική-Αθηνά
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38913